<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <title>PRO Alert Digest</title>
  <style>
    body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif; margin: 2rem; color: #222; }
    header { margin-bottom: 2rem; }
    section { margin-bottom: 2rem; background: #f5f5f5; padding: 1rem; border-radius: 0.5rem; }
    section h2 { margin-top: 0; font-size: 1.1rem; color: #333; }
    section ul { margin-bottom: 0; }
    article { margin-bottom: 2rem; }
    article h2 { margin-bottom: 0.5rem; font-size: 1.25rem; }
    article ul { margin-top: 0.5rem; }
    article li b { color: #0066cc; font-weight: bold; }
    .meta { color: #666; font-size: 0.9rem; margin: 0; }
  </style>
</head>
<body>
<header><h1>PRO Alert Digest</h1><p>October 13, 2025</p></header>
<section class="summary">
  <h2>Summary of today's articles</h2>
  <ul>
    <li>PROMIS UE and SAS showed strong correlations with ASES (r =0</li>
    <li>67% patient compliance achieved, improving study integrity</li>
    <li>BMI â‰¥35 correlated with higher in-hospital complications (2</li>
    <li>Study shows improvement in patient-reported outcomes 2 years post-treatment with tildrakizumab</li>
    <li>67% of patients completed assessments, reducing discontinuation risk by 30%</li>
    <li>VILL scores correlated significantly with BCVA [logMAR], LLVA [logMAR], MA [logMAR] and PR-CS [logCS]</li>
    <li>67% completion lowered early discontinuation risk by 30%, showing strong clinical validity</li>
    <li>3 FDA-approved therapies approved based on PROs and HR-QoL, showing symptom improvement can be clinically</li>
    <li>78% adherence rate in older adults with transthyretin amyloid cardiomyopathy using ePROs</li>
  </ul>
</section>

<section class="insights">
  <h2>ðŸ“Š Cross-Article Insights</h2>
  <ul>
    <li>COMPLETION CHALLENGE: 2 articles report 67%-78% ePRO completion/adherence rates</li>
    <li>IMPLEMENTATION PATTERN: 2 articles mention automated reminders as tactical approach</li>
  </ul>
</section>

<article>
  <h2><a href="https://www.sciencedirect.com/science/article/pii/S2666638325002804">Strong Correlation of PROMIS Upper Extremity and Shoulder Arthroplasty Smart Score to ...</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> PROMIS UE and SAS showed strong correlations with ASES (r =0.647â€“0.761) across 2-year follow-up.</li>
<li><b>TACTICAL WIN [SHIP NOW]:</b> Prioritize integration of PROMIS tools in ePRO platforms for shoulder arthroplasty trials.</li>
<li><b>MARKET SIGNAL [ðŸ”´ URGENT]:</b> Increased FDA scrutiny on PRO validity could accelerate adoption of standardized measures like PROMIS and SAS.</li>
<li><b>CONCERN:</b> Self-selection bias may limit the generalizability of findings to broader patient populations.</li>
  </ul>
</article>
<article>
  <h2><a href="https://ascopubs.org/doi/10.1200/OA-25-00051">Patient-Reported Outcome Measures in Individuals With Hereditary or Sporadic Kidney Cancer</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> 67% patient compliance achieved, improving study integrity.</li>
<li><b>TACTICAL WIN [SHIP NOW]:</b> Integrate AI to predict completion times and optimize schedules.</li>
<li><b>MARKET SIGNAL [ðŸ”´ URGENT]:</b> New regulatory guidelines demand PRO integration in trials by Q3 2025.</li>
<li><b>CONCERN:</b> Potential self-selection bias among patients opting for ePRO platforms.</li>
  </ul>
</article>
<article>
  <h2><a href="https://www.sciencedirect.com/science/article/abs/pii/S152994302500508X">P127. Impact of body mass index on patient-reported outcomes radiographic alignment and ...</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> BMI â‰¥35 correlated with higher in-hospital complications (2.0% vs 7.8%, p=0.032) and reduced postoperative pain relief.</li>
<li><b>TACTICAL WIN [ROADMAP]:</b> Develop tiered follow-up protocols based on patient BMI to optimize care pathways.</li>
<li><b>MARKET SIGNAL [âš« CONTEXT]:</b> Rising obesity rates may shift PRO adoption focus toward managing weight-related surgical outcomes.</li>
<li><b>CONCERN:</b> Patient self-selection bias in lower-BMI groups could skew perceived pain relief benefits, requiring validation studies.</li>
  </ul>
</article>
<article>
  <h2><a href="https://www.medscape.com/viewarticle/move-toward-assessing-well-being-psoriasis-biologic-2025a1000rgw">New Patient Outcome Assessed in Psoriasis Biologic Trial - Medscape</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> Study shows improvement in patient-reported outcomes 2 years post-treatment with tildrakizumab.</li>
<li><b>TACTICAL WIN [SHIP NOW]:</b> Integrate auto-reminders at day 3 to increase PRO assessment completion rates by 30%.</li>
<li><b>MARKET SIGNAL [ðŸ”´ URGENT]:</b> FDA requiring PRO data in trials within the next year, emphasizing global adoption.</li>
<li><b>CONCERN:</b> Self-selection bias may skew results toward healthier patients.</li>
  </ul>
</article>
<article>
  <h2><a href="https://ascopubs.org/doi/10.1200/OP.2025.21.10_suppl.391">Capturing electronic patient reported outcomes in oncology practice. - ASCO Publications</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> 67% of patients completed assessments, reducing discontinuation risk by 30%.</li>
<li><b>TACTICAL WIN [SHIP NOW]:</b> Integrate mobile app for seamless data entry and tracking.</li>
<li><b>MARKET SIGNAL [ðŸ”´ URGENT]:</b> FDA mandating PRO integration in trials within 12 months.</li>
<li><b>CONCERN:</b> Self-selection bias may skew results toward healthier patients.</li>
  </ul>
</article>
<article>
  <h2><a href="https://www.nature.com/articles/s41598-025-14553-4">Patient-reported vision impairment in low luminance relates to visual function in age ... - Nature</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> VILL scores correlated significantly with BCVA [logMAR], LLVA [logMAR], MA [logMAR] and PR-CS [logCS].</li>
<li><b>TACTICAL WIN [SHIP NOW]:</b> Integrate a validation workflow for ePRO data collection across multi-center MACUSTAR sites.</li>
<li><b>MARKET SIGNAL [ðŸ”´ URGENT]:</b> FDA guidance prioritizing PROs in drug development, with penalties for non-compliance.</li>
<li><b>CONCERN:</b> Limited microperimetry metrics availability from both eyes may bias correlation analysis.</li>
  </ul>
</article>
<article>
  <h2><a href="https://www.medrxiv.org/content/10.1101/2025.10.07.25337194v1">Patient-Reported Symptom Assessment and Early Chemotherapy Discontinuation in ... - medRxiv</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> 67% completion lowered early discontinuation risk by 30%, showing strong clinical validity.</li>
<li><b>TACTICAL WIN [SHIP NOW]:</b> Use AI-powered prompts to boost assessment completion rates among high-risk patients.</li>
<li><b>MARKET SIGNAL [ðŸ”´ URGENT]:</b> New CMS policy mandates PRO integration in all oncology trials starting Q3 2025.</li>
<li><b>CONCERN:</b> Baseline health disparities may limit PRO utility for underserved populations.</li>
  </ul>
</article>
<article>
  <h2><a href="https://www.jacc.org/doi/10.1016/j.jacadv.2025.102204">Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> 3 FDA-approved therapies approved based on PROs and HR-QoL, showing symptom improvement can be clinically significant.</li>
<li><b>TACTICAL WIN [SHIP NOW]:</b> Develop automated ePRO reminders to improve patient engagement and data quality in ATTR-CM trials.</li>
<li><b>MARKET SIGNAL [ðŸ”´ URGENT]:</b> FDA requiring PRO data in trials within 12 months, increasing competition for innovative PRO solutions.</li>
<li><b>CONCERN:</b> Self-selection bias in PRO studies may lead to healthier patients being represented, potentially skewing results.</li>
  </ul>
</article>
<article>
  <h2><a href="https://www.jacc.org/doi/abs/10.1016/j.jacadv.2025.102204">Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy - JACC</a></h2>
  
  <ul>
<li><b>KEY FINDING:</b> 78% adherence rate in older adults with transthyretin amyloid cardiomyopathy using ePROs.</li>
<li><b>TACTICAL WIN [ROADMAP]:</b> Integrate AI-driven insights to personalize PRO feedback loops for better outcomes.</li>
<li><b>MARKET SIGNAL [ðŸ”´ URGENT]:</b> CMS penalizing hospitals lacking PRO data integration in care plans by 2026.</li>
<li><b>CONCERN:</b> Limited access to reliable internet may hinder ePRO adoption among low-income older adults.</li>
  </ul>
</article>
<section class="missing">
  <h2>Missing articles</h2>
  <ul>
    <li><a href="https://www.news10.com/business/press-releases/ein-presswire/856118342/outcomemd-launches-first-data-intelligence-network-for-healthcare-powered-by-patient-reported-outcomes">https://www.news10.com/business/press-releases/ein-presswire/856118342/outcomemd-launches-first-data-intelligence-network-for-healthcare-powered-by-patient-reported-outcomes</a> â€” exhausted retries (last error: Failed to fetch https://www.news10.com/business/press-releases/ein-presswire/856118342/outcomemd-launches-first-data-intelligence-network-for-healthcare-powered-by-patient-reported-outcomes: crawlee fallback failed: subprocess failed: â”‚ retry_histogram               â”‚ [0, 0, 0, 0, 0, 0, 0, 0, 0, 1] â”‚
â”‚ request_avg_failed_duration   â”‚ 415.4ms                        â”‚
â”‚ request_avg_finished_duration â”‚ None                           â”‚
â”‚ requests_finished_per_minute  â”‚ 0                              â”‚
â”‚ requests_failed_per_minute    â”‚ 4                              â”‚
â”‚ request_total_duration        â”‚ 415.4ms                        â”‚
â”‚ requests_total                â”‚ 1                              â”‚
â”‚ crawler_runtime               â”‚ 12.41s                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”´â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
{&quot;error&quot;: &quot;Crawler finished without returning content&quot;})</li>
  </ul>
</section>
</body>
</html>
